These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31347343)

  • 1. Oral insulin: an update.
    Chatterjee S; Bhushan Sharma C; Lavie CJ; Adhikari A; Deedwania P; O'keefe JH
    Minerva Endocrinol; 2020 Mar; 45(1):49-60. PubMed ID: 31347343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of bolus insulin and advancing insulin therapy in type 2 diabetes.
    Karl DM
    Curr Diab Rep; 2004 Oct; 4(5):352-7. PubMed ID: 15461900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing insulin therapy in patients with type 1 and type 2 diabetes mellitus: optimal dosing and timing in the outpatient setting.
    Hahr AJ; Molitch ME
    Am J Ther; 2008; 15(6):543-50. PubMed ID: 19127139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Waiting to inhale: noninjectable insulin, are we there yet?
    Hermansen K
    Curr Diab Rep; 2004 Oct; 4(5):335-41. PubMed ID: 15461897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhaled human [rDNA origin] insulin, a novel formulation for diabetes mellitus.
    Pham DQ; Cohen H; Chu V
    J Clin Pharmacol; 2007 Jul; 47(7):890-903. PubMed ID: 17585117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral insulin - a review of current status.
    Iyer H; Khedkar A; Verma M
    Diabetes Obes Metab; 2010 Mar; 12(3):179-85. PubMed ID: 20151994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FlexPen: addressing issues of confidence and convenience in insulin delivery.
    Korytkowski M; Niskanen L; Asakura T
    Clin Ther; 2005; 27 Suppl B():S89-100. PubMed ID: 16519040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studying the Hurdles of Insulin Prescription (SHIP): development, scoring and initial validation of a new self-administered questionnaire.
    Martinez L; Consoli SM; Monnier L; Simon D; Wong O; Yomtov B; Guéron B; Benmedjahed K; Guillemin I; Arnould B
    Health Qual Life Outcomes; 2007 Aug; 5():53. PubMed ID: 17727695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral delivery of insulin for treatment of diabetes: status quo, challenges and opportunities.
    Wong CY; Martinez J; Dass CR
    J Pharm Pharmacol; 2016 Sep; 68(9):1093-108. PubMed ID: 27364922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninjectable methods of insulin administration.
    Cernea S; Raz I
    Timely Top Med Cardiovasc Dis; 2006 Nov; 10():E29. PubMed ID: 17136235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin and antidiabetic agents -- the old and the new.
    Golembiewski J
    J Perianesth Nurs; 2006 Apr; 21(2):131-4. PubMed ID: 16600835
    [No Abstract]   [Full Text] [Related]  

  • 12. Devices for insulin administration.
    Hill J
    Nurs Times; 2003 Apr 15-21; 99(15):51-2. PubMed ID: 12733296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review.
    DeWitt DE; Hirsch IB
    JAMA; 2003 May; 289(17):2254-64. PubMed ID: 12734137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [What is new in the treatment of diabetes mellitus?].
    Gain T
    Krankenpfl J; 2000 Oct; 38(9-10):328-31. PubMed ID: 11194350
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of insulin delivery devices in diabetes care.
    Garg SK
    Diabetes Technol Ther; 2010 Jun; 12 Suppl 1():S1-3. PubMed ID: 20515296
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhaled human insulin.
    Strack TR
    Drugs Today (Barc); 2006 Apr; 42(4):207-21. PubMed ID: 16703118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing insulin therapy in patients with type 1 and type 2 diabetes mellitus: optimal dosing and timing in the outpatient setting.
    Hahr AJ; Molitch ME
    Dis Mon; 2010 Mar; 56(3):148-62. PubMed ID: 20189500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Management of diabetes in general practice--current requirements. 2: Oral antidiabetics and insulin therapy].
    Mehnert H
    Fortschr Med; 1994 Apr; 112(12):163-6. PubMed ID: 8200602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled insulin product approved.
    Traynor K
    Am J Health Syst Pharm; 2014 Aug; 71(15):1238. PubMed ID: 25027522
    [No Abstract]   [Full Text] [Related]  

  • 20. Insulin glargine and glulisine SoloSTAR pens for the treatment of diabetes.
    Garg S; Kelly WC; Garg S
    Expert Rev Med Devices; 2008 Mar; 5(2):113-23. PubMed ID: 18331174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.